1
Mohamed SKIBA Mohamed SKIBA
Skiba Mohamed, Bounoure Frédéric, Lahiani Skiba Malika, Dechelotte Pierre: (Fr) Complexes dinclusion de cysteine, leur preparation et les compositions les contenant, (En) Cysteine inclusion complexes and compositions containing same. Aliscience, In Cyclo, Skiba Mohamed, Bounoure Frédéric, Lahiani Skiba Malika, Dechelotte Pierre, BREDEMA, September 12, 2008: WO/2008/107569

(EN) Inclusion complex or mixture of inclusion complexes based on one or more sulphurated amino acids, derivatives thereof or salts thereof, and on at least one cyclodextrin or derivative(s) thereof.(FR) Complexe d'inclusion ou mélange de complexes d'inclusion à base d'un ou plusieurs acides aminés ...


2
Mohamed SKIBA Mohamed SKIBA
Skiba Mohamed, Lahiani Malika, Bounoure Frédéric, Dechelotte Pierre: (Fr) Association de substance oleagineuse avec un melange dau moins deux cyclodextrines, (En) Association of oleaginous substance with a mixture of at least two cyclodextrins. In Cyclo, Skiba Mohamed, Lahiani Malika, Bounoure Frédéric, Dechelotte Pierre, BREESE DERAMBURE MAJEROWICZ, September 27, 2007: WO/2007/107679

(EN) The invention concerns a mixture of inclusion complexes comprising or consisting of (1) at least two different cyclodextrins selected among alpha-, beta- and gamma cyclodextrin and/or derivatives thereof, in particular derivatives thereof modified by primary and/or secondary hydroxyl groups, an ...


3
Mohamed SKIBA Mohamed SKIBA
Skiba Mohamed, Skiba Malika, Bounoure Frédéric, Dechelotte Pierre: (Fr) Composition homogene et stable, riche en substances oleagineuses a base dun produit laitier, son procede de preparation et ses utilisations, (En) Homogeneous and stable composition rich in oleaginous substances based on a milk product, method for the preparation thereof and uses thereof. In Cyclo, Skiba Mohamed, Skiba Malika, Bounoure Frédéric, Dechelotte Pierre, BREDEMA, December 18, 2008: WO/2008/152226

(EN) The present invention relates to a stable and homogeneous milk composition based on milk comprising at least one cyclodextrin and at least one oleaginous substance. It also relates to the preparation thereof and also to products prepared therefrom, such as food compositions, powders, medicinal ...


4
Fetissov Serguei, Dechelotte Pierre, Hamze Sinno Maria, Gilbert Daniele: Diagnosing neuropsychiatric disorders, eating disorders and metabolic diseases, by measuring affinity and/or avidity of antibody from biological sample directed against biological molecule and comparing obtained value with control value. Fetissov Serguei, Dechelotte Pierre, April 4, 2008: FR2906614-A1

Process for diagnosing neuropsychiatric disorders, eating disorders and/or metabolic diseases, comprises measuring the affinity and/or avidity of antibody from a biological sample directed against a biological molecule involved in the homeostasic regulation, in the motivational behavior and/or emoti ...


5

6
Petit André, Dechelotte Pierre: (Fr) Aliment normo ou hyperproteine, enrichi, et hypercalorique, (En) Normo or hyperproteinated, enriched and hypercaloric food product. Aliscience, Centre Hospitalier Universitaire de Rouen, Université de Rouen, Petit André, Dechelotte Pierre, BREDEMA, September 18, 2008: WO/2008/110694

(EN) The invention relates to a hypercaloric food product in solid form, that has a caloric density higher than or equal to 450 kcal/100 g of food product and that is normo- or hyper-proteinated, i.e. that has a protein content higher than 6 wt % relative to the total weight of the food product; the ...


7
Fetissov Serguei, Dechelotte Pierre, Hamze Sinno Maria, Gilbert Danièle: (Fr) Méthode de diagnostic de maladies neuropsychiatriques, de troubles du comportement alimentaire ou de maladies métaboliques, (En) Method of diagnosing neuropsychiatric diseases, eating disorders or metabolic diseases. Fetissov Serguei, Dechelotte Pierre, Hamze Sinno Maria, Gilbert Danièle, BREDEMA, April 10, 2008: WO/2008/040882

(EN) The invention relates to a method of diagnosing neuropsychiatric diseases, eating disorders and/or metabolic diseases, which comprises the steps consisting in: i) measuring the affinity and/or the avidity of antibodies, derived from a biological sample, directed against a biological molecule in ...



Click the thumbnails below to visualize the patent trend.